FDA Investigator Yvonne E Lozano

Yvonne E Lozano has conducted inspections on 46 sites in 9 countries as of 16 May 2002. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
46
Last Inspection Date:
16 May 2002
Investigator Role:
FDA Investigator
Redica ID:
100006556
Countries of Inspections:
Germany, Costa Rica, United States of America, Brazil, France, Italy, Sweden, Guatemala, Mexico
FDA Investigators that have inspected at least one site in common with Yvonne E Lozano:
Adam J Taylor, Aditi S Thakur, Alan M Barker, Alicia M Mozzachio, Amanda Dinaro, Amanda S Zorn, Amy Devlin, PhD, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew J Barrowcliff, Anthony R Ronga, Arsen Karapetyan, Ashley L Reiber, Azza Talaat, Barbara M Frazier, Brian D Nicholson, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Carl A Huffman, III, Carrie Ann Plucinski, Catherine J Laufmann, Chad E Schmear, Chad J Whitwell, Chad W Rice, Charles I Ann, Charles R Cote, RIC, Christina A Miller, Christine H Kujawski, Christopher D Leach, Clotia Cabbey Mensah, Daniel B Arrecis, Daniel J Brown, Dariusz Galezowski, David Perkins, Debra I Love, Debra Lboyd Seale, Denise M Digiulio, Donna A Katz, Doretha M Tonkins, Eboni S Funderburk, Elizabeth L Philpy, Elizabeth M Jacobson, Emily S Mcgann, Eric L Dong, BS, Eric M Mueller, PharmD, Evelyn Taha, Frank Wackes, Frederick F Razzaghi, Freed A Sharif, Gabryelle J Solverud, Howard Sklamberg, Humera T Khan, Jacob G Lutz, James M Kewley, James P Duggan, James W Plucinski, Janae D Price, Jason F Chancey, Jeanne J Chiu, Jennifer A D'angelo, Jennifer C Adams, Jennifer C Johnson, John M Seale, Jonathan G Swoboda, Joseph A Morkunas, Joseph A Piechocki, Joseph D Cooper, Joshua M Adams, Justin A Boyd, Kent C Faul, Kip J Hanks, Kristen E Szenderski, Kshitij A Patkar, Kujtim Sadiku, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, LCDR Mark A Jimenez, RN, Lee Terry Moore, Lequita M Mayhew, Linda F Murphy, Lisa C Lewis, Lisa Hayka, Lisa Hornback, Maksim A Levenchuk, Margaret Torres Vazquez, Marisa E Stock, Mark G Peterson, Mark R Mcclain, Martin R Vowell, Mathew T Thomas, MD, Matthew J Sienko, Michele L Glendenning, Michele Perry Williams, Milva E Melendez Perales, Mra Mcculloughj, Mra Munizn, Nibin Varghese, MS, Nicholas F Lyons, Nicholas J Presto, Nicholas P Diorio, Nicholas Z Lu, Nicole E Knowlton, Norman K Starks, Omotunde O Osunsanmi, Pablo Alcantara, Pal S Mayasandra, Patricia A Mcilroy, Patrick C Klotzbuecher, Patsy J Domingo, Patty P Kaewussdangkul, Paula A Trost, Paula P Demichael, Peng Zhou, Phung Thien Nguyen, Rafael Padilla, Ralph A Erickson, Ralph H Vocque, Raymond T Oji, Rebecca Parrilla, Rebecca Rodriguez, Renee L Anderson, Richard H Penta, Robert D Tollefsen, Robert J Martin, Roberta W Cunningham, Rochelle L Cross, Rosemary Wood Sexton, Roshni J Patel, Ross J Grigsby, Russell K Riley, Samina S Khan, Samuel T Walker, Sandra A Boyd, Sandra A Hughes, Sarah E Rhoades, Sarah Nwandiuko, Scott T Ballard, Shafiq S Ahadi, Shana L Williams, Stephen C Mahoney, Sullan, Susan D Yuscius, Susan P Bruederle, Susan W Ciani, Tamara Brey, Tara R Gooen, That Q Dang, Thomas J Arista, Todd M Stankewicz, Uruaku A Obasi, Vioela J Caze, Viviana Matta, Wayne E Seifert, Wendy G Tan, PhD

Yvonne E Lozano's Documents

Publish Date Document Type Title
August, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-08-16
March, 2001 FDA 483 E. Merck KGaA - Form 483, 2001-03-22
March, 2001 FDA 483 Response E. Merck KGaA - Form 483R, 2001-04-03
August, 2000 FDA 483 Adib F. Rodriguez Solares, M.D. - Form 483, 2000-08-04
March, 2001 FDA 483 Merck KGaA - Form 483, 2001-03-16
July, 2000 EIR Adriano Arguedas Mohs, M.D. - EIR, 2000-09-06
August, 2000 FDA 483 Response Adib F. Rodriguez Solares, M.D. - Form 483R, 2000-08-28
August, 2000 EIR Adib F. Rodriguez Solares, M.D. - EIR, 2000-08-02
February, 2000 FDA 483 Response Woodstock Sterile Solutions - Form 483R, 2000-02-24
August, 2001 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2001-09-07
May, 2000 EIR Phoenix Bean, LLC. - EIR, 2000-05-26
March, 2001 EIR E. Merck - EIR, 2001-05-16
May, 2000 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2000-05-04
September, 2001 EIR Innophos - EIR, 2001-09-24
May, 2000 FDA 483 Phoenix Bean, LLC. - Form 483, 2000-05-26
October, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-10-19
January, 2002 EIR Bracco Imaging S.p.A. - EIR, 2002-01-30
March, 2001 EIR E. Merck KGaA - EIR, 2001-06-07
May, 2000 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2000-05-04
February, 2000 EIR Woodstock Sterile Solutions - EIR, 2000-02-01
December, 2001 EIR Pharmaceutical Systems, Inc. - EIR, 2001-12-07
May, 2000 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2000-05-22
March, 2001 FDA 483 Response E. Merck - Form 483R, 2001-04-12
July, 2001 EIR Fresenius Kabi USA, LLC - EIR, 2001-07-20
January, 2002 FDA 483 Bracco Imaging S.p.A. - Form 483, 2002-01-30
February, 2000 FDA 483 Woodstock Sterile Solutions - Form 483, 2000-02-01
March, 2001 EIR Morton Grove Pharmaceuticals, Inc. - EIR, 2001-03-01
July, 2000 FDA 483 Response Adriano Arguedas Mohs, M.D. - Form 483R, 2000-08-30
March, 2001 FDA 483 Morton Grove Pharmaceuticals, Inc. - Form 483, 2001-03-01
September, 2001 FDA 483 Innophos - Form 483, 2001-09-24
March, 2001 FDA 483 Response Morton Grove Pharmaceuticals, Inc. - Form 483R, 2001-03-23
August, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-08-16
July, 2001 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2001-07-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more